Analyst initiated coverage on Mereo BioPharma with a new price target
$MREO
Biotechnology: Pharmaceutical Preparations
Health Care
Analyst initiated coverage of Mereo BioPharma with a rating of Overweight and set a new price target of $7.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/27/2025 | $7.00 | Overweight | Analyst |
| 12/6/2024 | $7.00 | Buy | Jefferies |
| 6/13/2024 | $8.00 | Outperform | Robert W. Baird |
| 10/13/2023 | $4.00 | Buy | BTIG Research |
| 8/12/2022 | $4.00 | Overweight | Cantor Fitzgerald |